Prognostic impact of diastolic dysfunction in systolic heart failure-A cross-project analysis from the German
Claus Lüers1, Frank Edelmann2,3, Rolf Wachter2
1University of Oldenburg, European Medical School Oldenburg-Groningen, Germany.
Insights
Diastolic dysfunction (DD) provides important prognostic information in heart failure patients with reduced ejection fraction. Its impact is most significant in those with non-severe systolic dysfunction (SD).
Area of Science:
- Cardiology
- Heart Failure Research
- Echocardiography
Background:
- Investigating the prognostic significance of diastolic dysfunction (DD) in heart failure (HF) patients with systolic dysfunction (SD).
- Assessing the modifying role of DD in HF patients with reduced left ventricular ejection fraction (LVEF).
Purpose of the Study:
- To determine if echocardiographic evaluation of diastolic function offers additional prognostic information in patients with systolic dysfunction.
- To analyze the combined prognostic impact of systolic and diastolic dysfunction in heart failure.
Main Methods:
- Echocardiographic study of 1046 heart failure patients with LVEF <50%.
- Patients were followed for a median of 5 years.
- Systolic dysfunction (SD) and diastolic dysfunction (DD) were categorized as non-severe or severe based on LVEF and E/E' values, respectively.
Main Results:
- Severe SD significantly increased risk for all endpoints (death, hospitalization).
- Severe DD also independently increased mortality risk.
- A significant interaction was observed: severe DD substantially increased risk in moderate SD, but added little risk in severe SD.
Conclusions:
- Diastolic function evaluation provides crucial additional prognostic information in HF patients with reduced LVEF.
- The prognostic impact of DD, particularly on mortality, is most relevant in patients with non-severe systolic dysfunction.
Background:
We investigated the modifying role and prognostic importance of diastolic dysfunction (DD) in patients with heart failure and systolic dysfunction (SD).
Hypothesis:
The echocardiographic evaluation of diastolic function in patients with SD provides further prognostic information.
Methods:
From the German Competence Network Heart Failure, 1046 heart failure patients with reduced left ventricular ejection fraction (LVEF; <50%) were echocardiographically studied and followed for a median of 5 years. SD was subdivided into nonsevere (LVEF 36%-49%) and severe (LVEF ≤35%); DD was subdivided into nonsevere (E/E' <15) and severe (E/E' ≥15).
Results:
In general, severe SD was associated with higher hazard ratios (HRs; 2-fold to 3.5-fold) for all endpoints (all-cause death, cardiac death, cardiovascular hospitalization, duration of hospitalization). Patients with severe SD had a 2.5-fold risk of death (95% confidence interval [CI]: 1.84-3.47, P < 0.001), and patients with severe DD showed a 1.8-fold risk (95% CI: 1.17-2.61, P = 0.004). Furthermore, we observed a strong interaction of SD and DD: concomitant severe DD in patients with moderate SD increased risk substantially (HR: 1.73, 95% CI: 1.16-2.6, P = 0.007); by contrast, in patients with severe SD, additional presence of severe DD added little or no risk (HR for interaction: 0.5-1.2).
Conclusions:
In heart failure patients with reduced LVEF, the evaluation of diastolic function provides additional prognostic information. Although severe SD generally increased the risk for all endpoints, the degree of DD and its impact as a prognostic marker for overall and cardiovascular mortality appeared of particular relevance in subjects with nonsevere SD.
More Related Videos
07:49A Pacing-Controlled Procedure for the Assessment of Heart Rate-Dependent Diastolic Functions in Murine Heart Failure Models
Published on: July 21, 2023
08:57Pulsed Wave Doppler Assessment of Diastolic Dysfunction in the ZSF-1 Rat Model of Pulmonary Hypertension Due to Left Heart Disease
Published on: May 22, 2026
Related Concept Videos
Pathophysiology of Heart Failure
Mitral Regurgitation I: Introduction
Heart Failure II: Pathophysiology
Heart Failure IV: Classification and Diagnostic Evaluation
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
